Laura Sutcliffe
Stock Analyst at Citi
(2.24)
# 3,010
Out of 4,592 analysts
502
Total ratings
50.3%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Maintained: Hold | $110.00 | $123.06 | -10.61% | 39 | Jul 29, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $31.00 | $14.21 | +118.16% | 36 | Jul 29, 2026 | |
| NZE: EBO EBOS Group Limited | Maintained: Buy | $31.16 → $29.37 | $22.04 | +33.24% | 5 | Jul 15, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Hold | n/a | $40.69 | - | 7 | Jul 15, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $240.00 | $162.21 | +47.96% | 7 | Jul 15, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $42.00 | $44.34 | -5.28% | 16 | Jul 15, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Sell | $95.00 → $100.00 | $119.94 | -16.62% | 16 | Jul 13, 2026 | |
| ASX: RMD ResMed Inc. | Downgraded: Hold | $38.00 → $34.00 | $29.79 | +14.13% | 20 | Jul 13, 2026 | |
| RMD ResMed | Downgraded: Hold | $270 → $235 | $210.98 | +11.38% | 14 | Jul 10, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $36.00 → $33.50 | $32.79 | +2.17% | 15 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21.50 → $19.00 | $21.86 | -13.08% | 15 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €40.00 → €34.00 | €23.86 | n/a | 14 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 86.00 → CHF 84.00 | CHF 126.60 | n/a | 61 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.10 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €118.00 → €103.00 | €74.47 | n/a | 56 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,850p → 1,820p | 1,932p | n/a | 85 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €87.00 | €217.88 | n/a | 16 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,880 → kr 2,600 | kr 1,833 | n/a | 16 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $28.87 | n/a | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $156.15 | n/a | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $390 | $853.82 | n/a | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $88 | $27.21 | n/a | 5 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €108.00 | €143.15 | n/a | 1 | Feb 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $43.08 | n/a | 1 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $51.69 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $303 → $300 | $47.08 | n/a | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $96 → $99 | $1,148.84 | n/a | 18 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $55 | $65.31 | n/a | 16 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $130.21 | n/a | 14 | Oct 18, 2017 |
CSL Limited
Jul 29, 2026
Maintained: Hold
Price Target: $110.00
Current: $123.06
Upside: -10.61%
Telix Pharmaceuticals Limited
Jul 29, 2026
Maintained: Buy
Price Target: $31.00
Current: $14.21
Upside: +118.16%
EBOS Group Limited
Jul 15, 2026
Maintained: Buy
Price Target: $31.16 → $29.37
Current: $22.04
Upside: +33.24%
Fisher & Paykel Healthcare Corporation Limited
Jul 15, 2026
Maintained: Hold
Price Target: n/a
Current: $40.69
Upside: -
Pro Medicus Limited
Jul 15, 2026
Maintained: Buy
Price Target: $240.00
Current: $162.21
Upside: +47.96%
Ramsay Health Care Limited
Jul 15, 2026
Maintained: Hold
Price Target: $42.00
Current: $44.34
Upside: -5.28%
Cochlear Limited
Jul 13, 2026
Maintained: Sell
Price Target: $95.00 → $100.00
Current: $119.94
Upside: -16.62%
ResMed Inc.
Jul 13, 2026
Downgraded: Hold
Price Target: $38.00 → $34.00
Current: $29.79
Upside: +14.13%
ResMed
Jul 10, 2026
Downgraded: Hold
Price Target: $270 → $235
Current: $210.98
Upside: +11.38%
Ansell Limited
Jul 6, 2026
Maintained: Hold
Price Target: $36.00 → $33.50
Current: $32.79
Upside: +2.17%
Jun 23, 2026
Maintained: Hold
Price Target: $21.50 → $19.00
Current: $21.86
Upside: -13.08%
May 7, 2024
Maintained: Hold
Price Target: €40.00 → €34.00
Current: €23.86
Upside: n/a
Dec 14, 2022
Maintained: Hold
Price Target: CHF 86.00 → CHF 84.00
Current: CHF 126.60
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: n/a
Current: $14.10
Upside: n/a
Aug 9, 2022
Downgraded: Hold
Price Target: €118.00 → €103.00
Current: €74.47
Upside: n/a
Aug 8, 2022
Maintained: Hold
Price Target: 1,850p → 1,820p
Current: 1,932p
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: €95.00 → €87.00
Current: €217.88
Upside: n/a
May 20, 2022
Maintained: Buy
Price Target: kr 2,880 → kr 2,600
Current: kr 1,833
Upside: n/a
Mar 16, 2022
Upgraded: Buy
Price Target: n/a
Current: $28.87
Upside: n/a
Nov 5, 2021
Downgraded: Hold
Price Target: n/a
Current: $156.15
Upside: n/a
Jun 18, 2021
Initiated Coverage: Buy
Price Target: $390
Current: $853.82
Upside: n/a
Apr 12, 2021
Maintained: Hold
Price Target: $86 → $88
Current: $27.21
Upside: n/a
Feb 28, 2020
Maintained: Hold
Price Target: €108.00
Current: €143.15
Upside: n/a
Aug 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $43.08
Upside: n/a
Feb 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $51.69
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: $303 → $300
Current: $47.08
Upside: n/a
Jul 25, 2018
Downgraded: Hold
Price Target: $96 → $99
Current: $1,148.84
Upside: n/a
Oct 26, 2017
Rated: Hold
Price Target: $55
Current: $65.31
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: $96
Current: $130.21
Upside: n/a